Copyright Reports & Markets. All rights reserved.

Global Human Oocyte Cryopreservation Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Human Oocyte Cryopreservation Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Slow Freezing
    • 1.2.3 Rapid Freezing
  • 1.3 Market by Application
    • 1.3.1 Global Human Oocyte Cryopreservation Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 25-30 Year Old Female
    • 1.3.3 30-35 Year Old Female
    • 1.3.4 35-40 Year Old Female
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Human Oocyte Cryopreservation Market Perspective (2016-2027)
  • 2.2 Human Oocyte Cryopreservation Growth Trends by Regions
    • 2.2.1 Human Oocyte Cryopreservation Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Human Oocyte Cryopreservation Historic Market Share by Regions (2016-2021)
    • 2.2.3 Human Oocyte Cryopreservation Forecasted Market Size by Regions (2022-2027)
  • 2.3 Human Oocyte Cryopreservation Industry Dynamic
    • 2.3.1 Human Oocyte Cryopreservation Market Trends
    • 2.3.2 Human Oocyte Cryopreservation Market Drivers
    • 2.3.3 Human Oocyte Cryopreservation Market Challenges
    • 2.3.4 Human Oocyte Cryopreservation Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Human Oocyte Cryopreservation Players by Revenue
    • 3.1.1 Global Top Human Oocyte Cryopreservation Players by Revenue (2016-2021)
    • 3.1.2 Global Human Oocyte Cryopreservation Revenue Market Share by Players (2016-2021)
  • 3.2 Global Human Oocyte Cryopreservation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Human Oocyte Cryopreservation Revenue
  • 3.4 Global Human Oocyte Cryopreservation Market Concentration Ratio
    • 3.4.1 Global Human Oocyte Cryopreservation Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Human Oocyte Cryopreservation Revenue in 2020
  • 3.5 Human Oocyte Cryopreservation Key Players Head office and Area Served
  • 3.6 Key Players Human Oocyte Cryopreservation Product Solution and Service
  • 3.7 Date of Enter into Human Oocyte Cryopreservation Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Human Oocyte Cryopreservation Breakdown Data by Type

  • 4.1 Global Human Oocyte Cryopreservation Historic Market Size by Type (2016-2021)
  • 4.2 Global Human Oocyte Cryopreservation Forecasted Market Size by Type (2022-2027)

5 Human Oocyte Cryopreservation Breakdown Data by Application

  • 5.1 Global Human Oocyte Cryopreservation Historic Market Size by Application (2016-2021)
  • 5.2 Global Human Oocyte Cryopreservation Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Human Oocyte Cryopreservation Market Size (2016-2027)
  • 6.2 North America Human Oocyte Cryopreservation Market Size by Type
    • 6.2.1 North America Human Oocyte Cryopreservation Market Size by Type (2016-2021)
    • 6.2.2 North America Human Oocyte Cryopreservation Market Size by Type (2022-2027)
    • 6.2.3 North America Human Oocyte Cryopreservation Market Size by Type (2016-2027)
  • 6.3 North America Human Oocyte Cryopreservation Market Size by Application
    • 6.3.1 North America Human Oocyte Cryopreservation Market Size by Application (2016-2021)
    • 6.3.2 North America Human Oocyte Cryopreservation Market Size by Application (2022-2027)
    • 6.3.3 North America Human Oocyte Cryopreservation Market Size by Application (2016-2027)
  • 6.4 North America Human Oocyte Cryopreservation Market Size by Country
    • 6.4.1 North America Human Oocyte Cryopreservation Market Size by Country (2016-2021)
    • 6.4.2 North America Human Oocyte Cryopreservation Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Human Oocyte Cryopreservation Market Size (2016-2027)
  • 7.2 Europe Human Oocyte Cryopreservation Market Size by Type
    • 7.2.1 Europe Human Oocyte Cryopreservation Market Size by Type (2016-2021)
    • 7.2.2 Europe Human Oocyte Cryopreservation Market Size by Type (2022-2027)
    • 7.2.3 Europe Human Oocyte Cryopreservation Market Size by Type (2016-2027)
  • 7.3 Europe Human Oocyte Cryopreservation Market Size by Application
    • 7.3.1 Europe Human Oocyte Cryopreservation Market Size by Application (2016-2021)
    • 7.3.2 Europe Human Oocyte Cryopreservation Market Size by Application (2022-2027)
    • 7.3.3 Europe Human Oocyte Cryopreservation Market Size by Application (2016-2027)
  • 7.4 Europe Human Oocyte Cryopreservation Market Size by Country
    • 7.4.1 Europe Human Oocyte Cryopreservation Market Size by Country (2016-2021)
    • 7.4.2 Europe Human Oocyte Cryopreservation Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Human Oocyte Cryopreservation Market Size (2016-2027)
  • 8.2 Asia-Pacific Human Oocyte Cryopreservation Market Size by Type
    • 8.2.1 Asia-Pacific Human Oocyte Cryopreservation Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Human Oocyte Cryopreservation Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Human Oocyte Cryopreservation Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Human Oocyte Cryopreservation Market Size by Application
    • 8.3.1 Asia-Pacific Human Oocyte Cryopreservation Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Human Oocyte Cryopreservation Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Human Oocyte Cryopreservation Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Human Oocyte Cryopreservation Market Size by Region
    • 8.4.1 Asia-Pacific Human Oocyte Cryopreservation Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Human Oocyte Cryopreservation Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Human Oocyte Cryopreservation Market Size (2016-2027)
  • 9.2 Latin America Human Oocyte Cryopreservation Market Size by Type
    • 9.2.1 Latin America Human Oocyte Cryopreservation Market Size by Type (2016-2021)
    • 9.2.2 Latin America Human Oocyte Cryopreservation Market Size by Type (2022-2027)
    • 9.2.3 Latin America Human Oocyte Cryopreservation Market Size by Type (2016-2027)
  • 9.3 Latin America Human Oocyte Cryopreservation Market Size by Application
    • 9.3.1 Latin America Human Oocyte Cryopreservation Market Size by Application (2016-2021)
    • 9.3.2 Latin America Human Oocyte Cryopreservation Market Size by Application (2022-2027)
    • 9.3.3 Latin America Human Oocyte Cryopreservation Market Size by Application (2016-2027)
  • 9.4 Latin America Human Oocyte Cryopreservation Market Size by Country
    • 9.4.1 Latin America Human Oocyte Cryopreservation Market Size by Country (2016-2021)
    • 9.4.2 Latin America Human Oocyte Cryopreservation Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Human Oocyte Cryopreservation Market Size (2016-2027)
  • 10.2 Middle East & Africa Human Oocyte Cryopreservation Market Size by Type
    • 10.2.1 Middle East & Africa Human Oocyte Cryopreservation Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Human Oocyte Cryopreservation Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Human Oocyte Cryopreservation Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Human Oocyte Cryopreservation Market Size by Application
    • 10.3.1 Middle East & Africa Human Oocyte Cryopreservation Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Human Oocyte Cryopreservation Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Human Oocyte Cryopreservation Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Human Oocyte Cryopreservation Market Size by Country
    • 10.4.1 Middle East & Africa Human Oocyte Cryopreservation Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Human Oocyte Cryopreservation Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Anova Fertility
    • 11.1.1 Anova Fertility Company Details
    • 11.1.2 Anova Fertility Business Overview
    • 11.1.3 Anova Fertility Human Oocyte Cryopreservation Introduction
    • 11.1.4 Anova Fertility Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.1.5 Anova Fertility Recent Development
  • 11.2 CCRM IVF
    • 11.2.1 CCRM IVF Company Details
    • 11.2.2 CCRM IVF Business Overview
    • 11.2.3 CCRM IVF Human Oocyte Cryopreservation Introduction
    • 11.2.4 CCRM IVF Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.2.5 CCRM IVF Recent Development
  • 11.3 Chill
    • 11.3.1 Chill Company Details
    • 11.3.2 Chill Business Overview
    • 11.3.3 Chill Human Oocyte Cryopreservation Introduction
    • 11.3.4 Chill Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.3.5 Chill Recent Development
  • 11.4 CREATE Fertility
    • 11.4.1 CREATE Fertility Company Details
    • 11.4.2 CREATE Fertility Business Overview
    • 11.4.3 CREATE Fertility Human Oocyte Cryopreservation Introduction
    • 11.4.4 CREATE Fertility Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.4.5 CREATE Fertility Recent Development
  • 11.5 Extend Fertility
    • 11.5.1 Extend Fertility Company Details
    • 11.5.2 Extend Fertility Business Overview
    • 11.5.3 Extend Fertility Human Oocyte Cryopreservation Introduction
    • 11.5.4 Extend Fertility Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.5.5 Extend Fertility Recent Development
  • 11.6 HRC Fertility
    • 11.6.1 HRC Fertility Company Details
    • 11.6.2 HRC Fertility Business Overview
    • 11.6.3 HRC Fertility Human Oocyte Cryopreservation Introduction
    • 11.6.4 HRC Fertility Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.6.5 HRC Fertility Recent Development
  • 11.7 IVF Australia
    • 11.7.1 IVF Australia Company Details
    • 11.7.2 IVF Australia Business Overview
    • 11.7.3 IVF Australia Human Oocyte Cryopreservation Introduction
    • 11.7.4 IVF Australia Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.7.5 IVF Australia Recent Development
  • 11.8 Kindbody
    • 11.8.1 Kindbody Company Details
    • 11.8.2 Kindbody Business Overview
    • 11.8.3 Kindbody Human Oocyte Cryopreservation Introduction
    • 11.8.4 Kindbody Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.8.5 Kindbody Recent Development
  • 11.9 London Women’s Clinic
    • 11.9.1 London Women’s Clinic Company Details
    • 11.9.2 London Women’s Clinic Business Overview
    • 11.9.3 London Women’s Clinic Human Oocyte Cryopreservation Introduction
    • 11.9.4 London Women’s Clinic Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.9.5 London Women’s Clinic Recent Development
  • 11.10 Manchester Fertility
    • 11.10.1 Manchester Fertility Company Details
    • 11.10.2 Manchester Fertility Business Overview
    • 11.10.3 Manchester Fertility Human Oocyte Cryopreservation Introduction
    • 11.10.4 Manchester Fertility Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.10.5 Manchester Fertility Recent Development
  • 11.11 Mayo Clinic
    • 11.11.1 Mayo Clinic Company Details
    • 11.11.2 Mayo Clinic Business Overview
    • 11.11.3 Mayo Clinic Human Oocyte Cryopreservation Introduction
    • 11.11.4 Mayo Clinic Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.11.5 Mayo Clinic Recent Development
  • 11.12 Melbourne IVF
    • 11.12.1 Melbourne IVF Company Details
    • 11.12.2 Melbourne IVF Business Overview
    • 11.12.3 Melbourne IVF Human Oocyte Cryopreservation Introduction
    • 11.12.4 Melbourne IVF Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.12.5 Melbourne IVF Recent Development
  • 11.13 Monash IVF
    • 11.13.1 Monash IVF Company Details
    • 11.13.2 Monash IVF Business Overview
    • 11.13.3 Monash IVF Human Oocyte Cryopreservation Introduction
    • 11.13.4 Monash IVF Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.13.5 Monash IVF Recent Development
  • 11.14 Pacific Fertility Center-Los Angeles (PFCLA)
    • 11.14.1 Pacific Fertility Center-Los Angeles (PFCLA) Company Details
    • 11.14.2 Pacific Fertility Center-Los Angeles (PFCLA) Business Overview
    • 11.14.3 Pacific Fertility Center-Los Angeles (PFCLA) Human Oocyte Cryopreservation Introduction
    • 11.14.4 Pacific Fertility Center-Los Angeles (PFCLA) Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.14.5 Pacific Fertility Center-Los Angeles (PFCLA) Recent Development
  • 11.15 PIVET
    • 11.15.1 PIVET Company Details
    • 11.15.2 PIVET Business Overview
    • 11.15.3 PIVET Human Oocyte Cryopreservation Introduction
    • 11.15.4 PIVET Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.15.5 PIVET Recent Development
  • 11.16 Prelude Fertility
    • 11.16.1 Prelude Fertility Company Details
    • 11.16.2 Prelude Fertility Business Overview
    • 11.16.3 Prelude Fertility Human Oocyte Cryopreservation Introduction
    • 11.16.4 Prelude Fertility Revenue in Human Oocyte Cryopreservation Business (2016-2021)
    • 11.16.5 Prelude Fertility Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Human Oocyte Cryopreservation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Oocyte Cryopreservation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Slow Freezing
    Rapid Freezing

    Segment by Application
    25-30 Year Old Female
    30-35 Year Old Female
    35-40 Year Old Female
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Anova Fertility
    CCRM IVF
    Chill
    CREATE Fertility
    Extend Fertility
    HRC Fertility
    IVF Australia
    Kindbody
    London Women’s Clinic
    Manchester Fertility
    Mayo Clinic
    Melbourne IVF
    Monash IVF
    Pacific Fertility Center-Los Angeles (PFCLA)
    PIVET

    Buy now